Stockreport

Calithera Biosciences announces clinical trial collaboration to evaluate IBRANCE and talazoparib in combination with CB-839 [Seeking Alpha]

Calithera Biosciences, Inc.  (CALA) 
Last calithera biosciences, inc. earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: calithera.com
PDF Calithera Biosciences announces clinical trial collaboration to evaluate IBRANCE and talazoparib in combination with CB-839 [Read more]